EE467 Estimation of Budget Impact With the Substitution of Biologic Reference Product for Biosimilars in Patients With Rheumatoid Arthritis From the Perspective of Medium Size Healthcare Insurance in Brazil
Abstract
Authors
Junior JM Alves FE Prota